Dnurse Technology Co., Limited is the first Chinese innovative mobile medical company whose mission is to reform the traditional diabetes management. Dnurse has successfully built the “Device + App + Service” innovative business mode through their advanced mobile smart glucose meter, their independently developed mobile app “Dnurse” and the cloud database. It provides diabetics a sustainable and effective diabetes self-management method. Dnurse is a new blood in the mobile heath care industry established in June 2013. Their founding team is composed with a senior engineer(CTO) and a senior executive(CEO) of one public mobile telecommunication company, and a Clinical Medical Science Doctor. Other team members are chronic disease management specialists and software developing specialists. This provides a strong medical science qualification and technology guarantee. Dnurse’s investors are Asia’s biggest diabetes marketing share holder Sinocare, Innovation Works and SAIF Partners. Sinocare provides advanced biochemical technology, marketing channels, registration, OTC sales channel support. In the other hand, Innovation Works provides sufficient internet talents, internet technology, business concept and promotional resources for Dnurse. Dnurse core innovation is using mobile internet technology successfully penetrated blood glucose testing, data storage, information sharing, doctor-patient communication for chronic diabetes management through organic combination of Dnurse patient version APP, Dnurse doctor version APP and Dnurse series smart glucose meter. It revolutionarily changes the traditional way of diabetes management, provides a reliable and efficient tool for diabetics behavior regulation, digital blood glucose management, complications incidence reduction and follow-up health care cost reduction etc...
With the maturity of big data technology, Dnurse has the accessibility of mass diabetics’ testing data about 20000 per day, which provides a medical database for the reference of diabetes prevention, diagnosis and treatment and eventually benefits the society. Dnurse has developed and launched the world’s first CFDA approval mobile earphone interface connecting, high-precision “Device + APP” patent smart glucose meter in Feb 2014. Dnurse series products:
Software: “Dnurse” app including patient and doctor version
Hardware (CFDA & CE):
Dnurse smartphone based glucose meter
GPRS glucose meter “Dnurse Xing”
（Dnurse serious products are all selling worldwide, for more info. Please check www.dnurse.com）
